Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial.

Dean A FennellSarah J Danson Penella J WollMartin ForsterDenis TalbotJennifer ChildLaura FarrellyAnnabel J Sharkey Sara BusaccaYenting NgaiAllan HackshawGraham Mark Wheeler

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)

Ganetespib can be combined safely with pemetrexed and platinum chemotherapy to treat patients with MPM. This class of agent should be investigated in larger randomized studies.

Keyphrases

small cell lung cancer
phase iii
phase ii
locally advanced
advanced non small cell lung cancer
open label
double blind
clinical trial
placebo controlled
study protocol
chemotherapy induced
radiation therapy
case control
mass spectrometry
epidermal growth factor receptor